{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:30:46Z","timestamp":1771327846653,"version":"3.50.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/mcg.0b013e31824e14a8","type":"journal-article","created":{"date-parts":[[2012,6,30]],"date-time":"2012-06-30T08:57:27Z","timestamp":1341046647000},"page":"764-767","source":"Crossref","is-referenced-by-count":8,"title":["The Effect of Intravenous Cyclosporine on Rates of Colonic Surgery in Hospitalized Patients With Severe Crohn\u2019s Colitis"],"prefix":"10.1097","volume":"46","author":[{"given":"Mark","family":"Lazarev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel H.","family":"Present","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Lichtiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asher","family":"Kornbluth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Marion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas A.","family":"Ullman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-11-20210305","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy.","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"R4-11-20210305","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/gast.2001.23983","article-title":"Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.","volume":"120","author":"DHaens","year":"2001","journal-title":"Gastroenterology"},{"key":"R5-11-20210305","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM198909283211301","article-title":"A placebo-controlled, double-blinded, randomized trial of cyclosporine therapy in active chronic Crohns disease.","volume":"321","author":"Brynskov","year":"1989","journal-title":"N Engl J Med"},{"key":"R6-11-20210305","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1056\/NEJM199406303302602","article-title":"Low-dose cyclosporine for the treatment of Crohns disease.","volume":"330","author":"Feagan","year":"1994","journal-title":"N Engl J Med"},{"key":"R7-11-20210305","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00042737-199406000-00009","article-title":"Cyclosporin Study Group of Great Britain and Ireland. Oral cyclosporine for chronic active Crohns disease: a multicentre controlled trial.","volume":"6","author":"Jewell","year":"1994","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R8-11-20210305","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/0016-5085(95)90384-4","article-title":"European trial of cyclosporine in chronic active Crohns diseasea 12 month study.","volume":"109","author":"Stange","year":"1995","journal-title":"Gastroenterology"},{"key":"R9-11-20210305","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00004836-199504000-00009","article-title":"Intravenous cyclosporine for steroid-refractory attacks of Crohns disease.","volume":"20","author":"Santos","year":"1995","journal-title":"J Clin Gastroenterol"},{"key":"R10-11-20210305","first-page":"1355","article-title":"Cyclosporine and 6-mercaptopurine for active, refractory Crohns colitis in children.","volume":"91","author":"Mahdi","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"R11-11-20210305","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/j.1572-0241.1998.00442.x","article-title":"Clinical outcome following treatment of refractory inflammatory and fistulizing Crohns disease with intravenous cyclosporine.","volume":"93","author":"Egan","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R12-11-20210305","first-page":"CD000297","article-title":"Cyclosporine for induction of remission in Crohns disease.","volume":"18","author":"McDonald","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R13-11-20210305","first-page":"315","article-title":"Cyclosporin therapy in inflammatory bowel disease: open-label experience.","volume":"57","author":"Lichtiger","year":"1990","journal-title":"Mt Sinai J Med"},{"key":"R14-11-20210305","first-page":"646","article-title":"Rapid closure of Crohns disease fistulas with continuous intravenous cyclosporine.","volume":"88","author":"Hanauer","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"R15-11-20210305","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF02090211","article-title":"The efficacy of cyclosporine in the treatment of the fistula of Crohns disease.","volume":"39","author":"Present","year":"1994","journal-title":"Dig Dis Sci"},{"key":"R16-11-20210305","first-page":"2003","article-title":"Intravenous cyclosporine for inflammatory bowel diseasesafe and effective.","volume":"54","author":"Chermesh","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"R17-11-20210305","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1572-0241.1999.01149.x","article-title":"Intravenous cyclosporine in ulcerative colitis: a five-year experience.","volume":"94","author":"Cohen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R18-11-20210305","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0016-5085(03)01214-9","article-title":"Randomized, double-blind comparison of 4 mgk versus 2 mgk intravenous cyclosporine in severe ulcerative colitis.","volume":"125","author":"Van Assche","year":"2003","journal-title":"Gastroenterology"},{"key":"R19-11-20210305","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.cgh.2006.04.001","article-title":"Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis.","volume":"4","author":"Moskovitz","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R20-11-20210305","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cgh.2008.04.035","article-title":"Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.","volume":"6","author":"Maser","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R21-11-20210305","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/gut.16.8.579","article-title":"Assessment of severity in colitis: a preliminary study.","volume":"16","author":"Lennard-Jones","year":"1975","journal-title":"Gut"},{"key":"R22-11-20210305","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MCG.0b013e3181e883dd","article-title":"Cyclosporine is safe and effective in patients with severe ulcerative colitis.","volume":"45","author":"Cheifetz","year":"2011","journal-title":"J Clin Gastroenterol"},{"key":"R23-11-20210305","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0399-8320(05)80754-7","article-title":"Efficacy of intravenous cyclosporin in moderately severe ulcerative colitis refractory to steroids.","volume":"29","author":"Message","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"key":"R24-11-20210305","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/S0016-5085(11)60453-8","article-title":"Cyclosporin versus infliximab in severe acute ulcerative colitis refractory to intravenous steroids: a randomized trial.","volume":"140","author":"Laharie","year":"2011","journal-title":"Gastroenterology"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004836-201210000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:27:24Z","timestamp":1618036044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-201210000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e31824e14a8","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}